Support-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

DK2020
2021-06-20

Support

BRIEF-Thermo Fisher Scientific Introduces New Quick To Clinic Solution To Help Biologic Drug Developers

June 14 (Reuters) - Thermo Fisher Scientific Inc : * THERMO FISHER SCIENTIFIC INTRODUCES NEW QUI

BRIEF-Thermo Fisher Scientific Introduces New Quick To Clinic Solution To Help Biologic Drug Developers

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":165252111,"tweetId":"165252111","gmtCreate":1624148588033,"gmtModify":1703829341330,"author":{"id":3572054231110959,"authorId":3572054231110959,"authorIdStr":"3572054231110959","name":"DK2020","avatar":"https://static.itradeup.com/news/de25000cb9a4ebdc52db3e1ab022b523","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Support</p></body></html>","htmlText":"<html><head></head><body><p>Support</p></body></html>","text":"Support","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/165252111","repostId":2143993787,"repostType":2,"repost":{"id":"2143993787","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623675457,"share":"https://www.laohu8.com/m/news/2143993787?lang=&edition=full","pubTime":"2021-06-14 20:57","market":"us","language":"en","title":"BRIEF-Thermo Fisher Scientific Introduces New Quick To Clinic Solution To Help Biologic Drug Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=2143993787","media":"Reuters","summary":"June 14 (Reuters) - Thermo Fisher Scientific Inc   :   * THERMO FISHER SCIENTIFIC INTRODUCES NEW QUI","content":"<html><body><p>June 14 (Reuters) - Thermo Fisher Scientific Inc   :</p><p>   * THERMO FISHER SCIENTIFIC INTRODUCES NEW QUICK TO CLINIC SOLUTION TO HELP BIOLOGIC DRUG DEVELOPERS ACCELERATE PRECLINICAL DEVELOPMENT AT BIO DIGITAL 2021</p><p>   * THERMO FISHER SCIENTIFIC - ENHANCED SOLUTION DELIVERS BALANCE OF SPEED, QUALITY TO ACCELERATE, EXPEDITE DNA TO IND IN AS LITTLE AS 13 MONTHS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Thermo Fisher Scientific Introduces New Quick To Clinic Solution To Help Biologic Drug Developers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Thermo Fisher Scientific Introduces New Quick To Clinic Solution To Help Biologic Drug Developers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-14 20:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 14 (Reuters) - Thermo Fisher Scientific Inc   :</p><p>   * THERMO FISHER SCIENTIFIC INTRODUCES NEW QUICK TO CLINIC SOLUTION TO HELP BIOLOGIC DRUG DEVELOPERS ACCELERATE PRECLINICAL DEVELOPMENT AT BIO DIGITAL 2021</p><p>   * THERMO FISHER SCIENTIFIC - ENHANCED SOLUTION DELIVERS BALANCE OF SPEED, QUALITY TO ACCELERATE, EXPEDITE DNA TO IND IN AS LITTLE AS 13 MONTHS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TMO":"赛默飞世尔","NGD":"New Gold"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143993787","content_text":"June 14 (Reuters) - Thermo Fisher Scientific Inc   :   * THERMO FISHER SCIENTIFIC INTRODUCES NEW QUICK TO CLINIC SOLUTION TO HELP BIOLOGIC DRUG DEVELOPERS ACCELERATE PRECLINICAL DEVELOPMENT AT BIO DIGITAL 2021   * THERMO FISHER SCIENTIFIC - ENHANCED SOLUTION DELIVERS BALANCE OF SPEED, QUALITY TO ACCELERATE, EXPEDITE DNA TO IND IN AS LITTLE AS 13 MONTHSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":194,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}